Phlebopathies: from pathogenesis to treatment

Introduction. The prevalence of phlebopathies varies from 15 to 31%. The QoL of patients with phlebopathies is impaired. Phlebotropic therapy is the main method for treating phlebopathies. Aim. Evaluation of the efficacy and safety of micronized purified flavonoid fraction (MPFF) (Troxaktiv). Materi...

Full description

Bibliographic Details
Published in:Амбулаторная хирургия
Main Authors: V. Yu. Bogachev, B. V. Boldin, P. Yu. Turkin, O. V. Dzhenina, O. A. Alukhanyan, N. V. Bogacheva
Format: Article
Language:Russian
Published: Remedium Group LTD 2023-11-01
Subjects:
Online Access:https://www.a-surgeon.ru/jour/article/view/386

Similar Items